Biosortia Pharmaceuticals

Biosortia is working on new drugs from deep access to the chemistry of the microbiome for immuno-oncology & immunological therapeutics.

Launch date

2008

Employees

Market cap

Net debt

Enterprise valuation

Dublin Ohio (HQ)

Get premium to view all results

Date	Investors	Amount	Round
Nov 2012	N/A	$0.0	round
Jan 2016	investor	$0.0	round
Aug 2016	N/A	$0.0	round
Oct 2017	N/A	$3.5m	Seed
Total Funding		000k

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Biosortia Pharmaceuticals